Mr. Small has served as Neurotech’s chief executive officer since 2016. He has more than of 30 years of both private and public company life sciences experience and more than 40 years of overall financial and operational management experience. He also currently serves as a trustee, executive committee member, and chairman of the Finance and Business Affairs Committee for the New England College of Optometry. Previously, Mr. Small helped start and served as senior vice president and Chief Financial Officer of Point Therapeutics, a life science company focused in developing oncology-based treatments. Prior to Point, he served as vice president and chief financial officer of Immulogic Pharmaceutical, Inc., a life science company developing treatments for immunological-based disorders. His early career was spent in senior management financial and treasury positions at Dennison Manufacturing Company and he began his career at the public accounting firm of Coopers and Lybrand, LLC. Mr. Small is a CPA and has a BS in business administration from Northeastern University.